Showing 181 to 195 of 450 results
Update on our new fee proposals
Your concerns, arguments, and views about the impact of HCPC’s proposed fee rise have prompted us to re-think our approach.
Update on our registration fees
Your concerns, arguments, and views about the impact of HCPC’s proposed fee rise have prompted us to re-think our approach.
Position statement: Taking part in industrial action
If you are an HCPC registrant taking part in industrial action, the behaviours set out in our standards of conduct, performance and ethics still apply
What our Fitness to practise annual report shows
The level of public concern in our professions remains small, but it is rising
HCPC responds to COVID-19 Vaccines Delivery Plan
The UK Government published its COVID-19 Vaccines Delivery Plan on Monday 11th January.
Occupational therapists renewal window closing soon
The deadline for occupational therapists to complete their registration renewal is fast approaching
Orthoptists and paramedics renewal window closing soon
The deadline for orthoptists and paramedics to complete their registration renewal is fast approaching
Dietitians renewal window closing soon
The deadline for dietitians to complete their registration renewal is fast approaching
Physiotherapists renewals - window closing soon
The deadline for physiotherapists to complete their registration renewal is fast approaching
Radiographers renewals - window closing soon
The deadline for radiographers to complete their registration renewal is fast approaching
Biomedical scientists renewals - window closing soon
The deadline for biomedical scientists to complete their registration renewal is fast approaching
Dietitian renewals - window closing soon
The deadline for dietitians to complete their registration renewal is fast approaching
Occupational therapists renewals - window closing soon
The deadline for occupational therapists to complete their registration renewal is fast approaching
Joint statement on meeting regulatory standards during periods of global or national shortage of medicines
We are concerned to hear that people with Type 2 diabetes are experiencing problems accessing GLP-1 receptor agonists (GLP-1 RAs).